Inpatient Reimbursement
In 2022, BONESUPPORT was granted NTAP (New Technology Add-on Payment) for CERAMENT® G — The First and Only Injectable Antibiotic-Eluting Bone Graft Substitute
Reimbursement and Coding for CERAMENT® G
Removing Financial Barriers for Patients and Providers
CERAMENT®G with Gentamicin has been designated by the FDA as a “Breakthrough Device”. This designation has allowed easier access to reimbursement programs through the Centers for Medicare and Medicaid Services (CMS) for both the inpatient and outpatient settings. The purpose of these programs is to expand patient access to new technology that CMS deems as worth adopting and help ease the decisions between cost and care.
Inpatient Reimbursement Program
In the spring of 2022 CMS approved CERAMENT G for a New Technology Add-On Payment. New Technology Add-On Payment (NTAP) is intended to provide inpatient admissions with additional payment for the use of CERAMENT G with Gentamicin when the hospital costs exceed the payment threshold. Payment varies based on costs exceeding the payment threshold with a max payment of $4,918.55.
Reimbursement:
- $4918 maximum reimbursement
- ICD-10-PCS Code: XW0V0P7
New technology add on payment (NTAP):
- Offsets product cost, reducing financial impact
- Unique ICD-10 Procedure Code
- Supports access to new technology
REIMBURSEMENT HOTLINE:
- Email: usreimbursement@bonesupport.com
- Phone: 1-866-903-2663
TO ORDER CERAMENT® G:
- Phone: 1-877-719-6718
- Email: us.sales@bonesupport.com
